Interventional cardiology devices are medical devices used in the diagnosis and treatment of cardiovascular disease. These devices are used in minimally invasive procedures that are performed through a small incision or puncture, rather than through open surgery. According to the latest research, the interventional cardiology devices market in Brazil is poised to grow by USD 80.2 million during 2023-2029, progressing at a CAGR of 5.2% during the forecast period. Minimally invasive procedures are becoming increasingly popular among patients and healthcare providers, as they offer several benefits over traditional open surgery, such as reduced risk of infection, shorter hospital stays, and faster recovery times. Interventional cardiology devices are often used in minimally invasive procedures, which is driving demand for these devices.
This industry report offers market estimates of the Brazil market, followed by a detailed analysis of the product. The Brazil market data on interventional cardiology devices can be segmented by product: cardiac catheters, coronary guidewires, coronary stents (bare metal stents, bioabsorbable stents, covered stents and drug eluting stents), intravascular ultrasound systems (IVUS), PTCA balloon catheters. The coronary stents segment held the largest share of the Brazil interventional cardiology devices market in 2022 and is anticipated to hold its share during the forecast period.
The Brazil interventional cardiology devices market is highly competitive. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Biotronik AG, Boston Scientific Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic Plc, MicroPort Scientific Corporation, Sahajanand Medical Technologies Pvt. Ltd., Terumo Corporation.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
▹ Get a detailed picture of the Brazil Interventional Cardiology Devices Market
▹ Identify segments/areas to invest in over the forecast period in the Brazil Interventional Cardiology Devices Market
▹ Understand the competitive environment, the market’s leading players
▹ The market estimate for ease of analysis across scenarios in Excel format.
▹ Strategy consulting and research support for three months.
▹ Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2022 |
| Forecast Year | 2023-2029 |
| CAGR (2023-2029) | 5.2% |
| Pages | 19 |
| Key Players | Abbott Laboratories, B. Braun Melsungen AG, Biotronik AG, Boston Scientific Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic Plc, MicroPort Scientific Corporation, Sahajanand Medical Technologies Pvt. Ltd., Terumo Corporation |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
